Japanese Tobacco Stock News

Fukuoka Financial Group has announced broad changes to its board and officer lineup across the holding company and core banks from April 2026, with additional director retirements and new audit committee appointments to be finalized at the June 2026 shareholders’ meeting. This governance refresh highlights a renewed emphasis on board oversight and risk management that could reshape how the group is supervised and run. We will now examine how this governance overhaul, particularly the planned...

Fujikura recently approved a policy to invest up to ¥300.00 billion to roughly triple optical fiber and SWR®/WTC® cable capacity in Japan and the US, supporting AI data center infrastructure under a Japan–US memorandum and a framework agreement with the US Department of Commerce. Alongside this capacity build-out, Fujikura’s role in US Conec’s expanded-beam MMC VSFF platform signals a deeper integration into the high-density optical connectivity ecosystem underpinning AI networks. We’ll now...

Leadership change talks put Sumitomo Mitsui Financial Group in focus Sumitomo Mitsui Financial Group (TSE:8316) has called a board meeting for March 6, 2026, to consider changes in its Representative Executive Officer, putting leadership and potential shifts in management priorities on investors’ radar. See our latest analysis for Sumitomo Mitsui Financial Group. The leadership news lands after a mixed spell in the market, with a 1 day share price return of 2.54% following a 30 day share...

Daikin Industries recently presented at the 2026 J.P. Morgan Industrials Conference in Washington, outlining its North American growth plans in inverter technology, low-GWP refrigerants, and heat pumps. The company also emphasized data center cooling as a key growth avenue, aiming to evolve into an integrated thermal-infrastructure partner in the U.S. market. We will now examine how this focus on data center cooling and thermal infrastructure could influence Daikin’s broader investment...

Sumitomo Chemical Company (TSE:4005) drew attention after a 3.40% intraday move on March 14, 2026, accompanied by heavy trading volume tied to sector flows into basic materials. See our latest analysis for Sumitomo Chemical Company. That surge in activity sits against a mixed recent pattern, with a 90 day share price return of 15.92%, a 30 day share price return decline of 11.33%, and a 1 year total shareholder return of 39.92%. This suggests that momentum has recently cooled after a strong...

Capcom (TSE:9697) is back in focus after Resident Evil Requiem sales surpassed 6 million units, reaching this milestone faster than any prior series entry and coinciding with extensive 30th anniversary content and collaboration plans. See our latest analysis for Capcom. Those game successes and esports events have come alongside a 17.0% 1 month share price return and a softer year to date share price performance of 2.4% decline. Meanwhile, 3 year total shareholder return sits at 62.1%,...

Nichirei Corporation recently held a board meeting where it approved a substantial capital increase for its European sub-subsidiary, Nichirei Holding Holland B.V., to fund new refrigerated warehouses and expand cold-chain logistics operations across Europe. This move underlines Nichirei’s intent to deepen its presence in the European cold-chain market by enhancing high value-added logistics services and long-term operating capabilities. We will now examine how this capital injection into...

Astellas Pharma and the HOVON Foundation reported that the Phase 3 HOVON 156/AMLSG 28-18/PASHA trial of XOSPATA (gilteritinib) in newly diagnosed FLT3-mutated acute myeloid leukemia did not meet its primary endpoint of overall survival at the primary analysis, with overall survival and safety broadly similar to midostaurin-based treatment. Although Astellas expects only a minor impact on financial results for the fiscal year ending March 31, 2026, the outcome underscores how clinical...

Dai-ichi Life Holdings has completed its share repurchase program announced in May 2025, buying back 79,682,200 shares, or 2.18% of its stock, for ¥99,999.99 million, with the final tranche executed between January 1 and March 9, 2026, and the plan formally closed on March 9. This completed buyback meaningfully reduces the share count and underscores management’s capital return focus at a time of ongoing business transformation. We’ll now examine how the completion of this sizeable share...

Disruptions to Qatar’s natural gas processing during the Iran war have pushed helium prices sharply higher, exposing global supply vulnerabilities while Iwatani, Japan’s leading helium supplier, reports it has so far kept deliveries stable through US sourcing and stockpiles. The episode highlights how concentrated helium production leaves industrial gas companies like Iwatani highly exposed to geopolitical risk despite contingency measures. Next, we’ll examine how heightened geopolitical...

Nomura Real Estate Master Fund (TSE:3462) is reshaping its portfolio by selling the aging NRE Hiroshima Building and acquiring two newer Tokyo properties, GEMS Tachikawa and PROUD FLAT Kiyosumidori, for a combined ¥8,880 million. See our latest analysis for Nomura Real Estate Master Fund. Recent asset recycling comes as the unit price has shown mixed momentum, with a 1 year total shareholder return of 20.33% contrasting with a weaker year to date share price return of a 5.32% decline. This...

Keio (TSE:9008) has just wrapped up a share repurchase program and completed a ¥9,999.75 million buyback, while also issuing ¥10 billion in unsecured green bonds with a fixed 1.537% coupon. See our latest analysis for Keio. Keio's latest ¥3,887 share price comes after a 1 day share price return of 0.67%. However, the 30 day share price return of a 4.64% decline and the 5 year total shareholder return of a 45.55% loss suggest longer term momentum has been weak, even as the recent buyback and...

Fuso ChemicalLtd (TSE:4368) has drawn fresh attention after a 13 March 2026 board meeting to review a manufacturing facility plan for its Kyoto Plant, raising questions about future capacity and capital allocation. See our latest analysis for Fuso ChemicalLtd. At a share price of ¥9,240.0, Fuso ChemicalLtd has seen firm momentum recently, with a 1 day share price return of 3.94% and a 90 day share price return of 46.90%. The 1 year total shareholder return of 161.92% points to strong longer...

Japan Airlines (TSE:9201) updated investors on 2 March 2026 by raising its earnings guidance, lifting dividend forecasts for the current fiscal year, and initiating work on a new growth strategy following a board meeting. See our latest analysis for Japan Airlines. Despite the raised earnings and dividend guidance, Japan Airlines’ 30 day share price return of 16.7% and year to date share price return decline of 12.2% suggest momentum has recently cooled, even though the 1 year total...

Event context and recent share moves Sapporo Holdings (TSE:2501) shares recently closed at ¥1,625, with a 0.8% move over the past day, a 2.7% decline over the past week, and a 13.6% decline over the past month. See our latest analysis for Sapporo Holdings. The recent 13.6% 1 month share price return contrasts with a slightly positive 90 day move and is set against a 1 year total shareholder return of 4.7%. This suggests momentum has cooled after a strong multi year run that includes a very...

In early March 2026, Kyowa Kirin Co., Ltd. announced it would discontinue all clinical trials of rocatinlimab, an investigational anti-OX40 antibody for moderate-to-severe atopic dermatitis, prurigo nodularis, and asthma, following a planned safety review conducted with partner Amgen. The decision was driven by emerging malignancy signals, including confirmed and suspected cases of Kaposi’s sarcoma that, despite low overall incidence, raised plausible mechanistic concerns about OX40 pathway...

Resona Holdings, Inc. recently approved changes to its top leadership, appointing long-time insider Shinichiro Isa as Deputy President, Representative Executive Officer, Group CFO and Group CDO, and elevating Nobuki Iwadate to Group Chief Human Resources Officer, Deputy President and Representative Executive Officer, effective April 1, 2026. The concentration of financial, digital and human capital oversight in the hands of two experienced internal leaders may meaningfully influence how...

Sompo Holdings (TSE:8630) has put governance and trust at the center of its story, updating regulators on reforms around fraudulent auto claims, premium practices, and data leaks that previously challenged its reputation. See our latest analysis for Sompo Holdings. Alongside these governance updates and the Aspen integration in the UK, Sompo Holdings’ ¥5,829 share price comes after a 90 day share price return of 12.10% and a 1 year total shareholder return of 32.92%. The 3 year total...

Why SBI Holdings (TSE:8473) just moved its dividend goalposts SBI Holdings (TSE:8473) has raised its year end dividend forecast to ¥75 per share and highlighted a completed ¥50b share buyback, following a board decision tied to profits in its Financial Services Business. See our latest analysis for SBI Holdings. The updated dividend and completed ¥50b buyback come after a weaker run in the share price, with a 30 day share price return of 17.6% and a year to date return of 14.26%. This...

Kyoto Financial Group Inc (TSE:5844) has drawn investor attention after sharply raising its earnings guidance, funded by large gains on equity sales, and pairing that move with a special dividend and expanded share buyback plan. See our latest analysis for Kyoto Financial GroupInc. The flurry of guidance upgrades, special dividend plans and the expanded buyback has coincided with strong recent momentum, with a 30 day share price return of 15.21% and a 1 year total shareholder return of...

Governance dispute focuses attention on Kobayashi Pharmaceutical Oasis Management’s public campaign against Kobayashi Pharmaceutical (TSE:4967) and its move to a Company with an Audit and Supervisory Committee has pushed the company’s governance structure and board oversight firmly into the spotlight for shareholders. See our latest analysis for Kobayashi Pharmaceutical. The governance dispute has arrived after a period where the 90 day share price return of 7.41% contrasts with a weaker 3...

Why IHI (TSE:7013) is on investors’ radar today IHI (TSE:7013) has recently drawn attention after a period of mixed share performance, with a negative month but a strong past 3 months and 1 year total return. This has prompted fresh questions about how its current valuation lines up with fundamentals. See our latest analysis for IHI. At a share price of ¥3,734.0, IHI has recently seen a 10.02% 1 month share price decline, following a strong 27.42% 3 month share price return and a very large 5...

Internet Initiative Japan (TSE:3774) has introduced a new Internal Vulnerability Assessment service within its Safous Security Assessment offering, giving customers broader visibility into security risks across internal networks and distributed sites. See our latest analysis for Internet Initiative Japan. The new security service arrives as Internet Initiative Japan’s share price trades at ¥2,333.5, with a 7 day share price return of 3.55% and a 30 day share price return of 4.97%. This...

Mitsubishi UFJ Financial Group (TSE:8306) has announced significant leadership changes at the senior executive level. Takuya Tanaka has been appointed Senior Managing Corporate Executive with responsibilities linked to commercial banking and wealth management. Yoshiaki Ueno has been appointed Managing Corporate Executive with a focus on corporate planning and group level management. These appointments mark a reshuffling of top roles that could influence group wide priorities and capital...